Francesco Claudi

649 total citations
48 papers, 511 citations indexed

About

Francesco Claudi is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Francesco Claudi has authored 48 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 19 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Francesco Claudi's work include Synthesis and Reactivity of Heterocycles (10 papers), Cyclopropane Reaction Mechanisms (10 papers) and Synthesis and Reactions of Organic Compounds (7 papers). Francesco Claudi is often cited by papers focused on Synthesis and Reactivity of Heterocycles (10 papers), Cyclopropane Reaction Mechanisms (10 papers) and Synthesis and Reactions of Organic Compounds (7 papers). Francesco Claudi collaborates with scholars based in Italy, United States and Spain. Francesco Claudi's co-authors include Sante Martelli, Mario Grifantini, Ippolito Antonini, Palmarisa Franchetti, Gianfabio Giorgioni, Antonio Di Stefano, Gloria Cristalli, Fabrizio Venturi, Massimo Ricciutelli and Walter Balduini and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Phytochemistry.

In The Last Decade

Francesco Claudi

44 papers receiving 483 citations

Peers

Francesco Claudi
Achintya K. Sinhababu United States
Michael F. Lipton United States
M. Harfenist United States
U. PINDUR Germany
T. W. HALL Canada
Mark C. McMills United States
Francesco Claudi
Citations per year, relative to Francesco Claudi Francesco Claudi (= 1×) peers Jacques H. Poupaert

Countries citing papers authored by Francesco Claudi

Since Specialization
Citations

This map shows the geographic impact of Francesco Claudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Claudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Claudi more than expected).

Fields of papers citing papers by Francesco Claudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Claudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Claudi. The network helps show where Francesco Claudi may publish in the future.

Co-authorship network of co-authors of Francesco Claudi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Claudi. A scholar is included among the top collaborators of Francesco Claudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Claudi. Francesco Claudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giorgioni, Gianfabio, Francesco Claudi, Massimo Ricciutelli, et al.. (2010). Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as l-DOPA prodrugs. Bioorganic & Medicinal Chemistry. 18(5). 1834–1843. 26 indexed citations
2.
Giorgioni, Gianfabio, Antonio Di Stefano, Piera Sozio, et al.. (2008). Glycosyl and polyalcoholic prodrugs of lonidamine. Bioorganic & Medicinal Chemistry Letters. 18(7). 2445–2450. 11 indexed citations
3.
Giorgioni, Gianfabio, et al.. (2008). Synthesis and Pharmacological Evaluation of 4-Phenoxy-1,2,3,4- Tetrahydroisoquinolines and 4,5,6,6a-Tetrahydrochromeno [2,3,4-de]isoquinolines. Medicinal Chemistry. 4(1). 1–10. 5 indexed citations
4.
Stefano, Antonio Di, Gianfabio Giorgioni, Massimo Ricciutelli, et al.. (2001). Dimeric l-Dopa Derivatives as Potential Prodrugs. Bioorganic & Medicinal Chemistry Letters. 11(8). 1085–1088. 26 indexed citations
5.
Stefano, Antonio Di, Gianfabio Giorgioni, Luigi Brunetti, et al.. (2001). Synthesis and preliminary pharmacological evaluation of 5-Hydroxy- and 5,6-dihydroxy-1,2,3,7,12,12a-hexahydrobenzo[5,6]cyclohepta[1,2,3-ij]isoquinoline derivatives as dopamine receptor ligands. Bioorganic & Medicinal Chemistry. 9(6). 1447–1458. 4 indexed citations
6.
Stefano, Antonio Di, et al.. (2000). Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of l-dopa. Bioorganic & Medicinal Chemistry Letters. 10(12). 1385–1388. 34 indexed citations
7.
Claudi, Francesco, Antonio Di Stefano, Gianfabio Giorgioni, et al.. (2000). Binding and Preliminary Evaluation of 5-Hydroxy- and 10-Hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as Dopamine Receptor Ligands. Journal of Medicinal Chemistry. 43(4). 599–608. 17 indexed citations
8.
Claudi, Francesco, et al.. (1995). New 2-pyridylethylamines with dopaminergic activity: Synthesis and radioligand-binding evaluation. European Journal of Medicinal Chemistry. 30(5). 415–421. 11 indexed citations
9.
Claudi, Francesco, et al.. (1994). Synthesis and evaluation of 2-(5-methoxythiophen-3-yl)ethylamines as potential dopamine agonists. European Journal of Medicinal Chemistry. 29(6). 423–429. 3 indexed citations
10.
Claudi, Francesco, Gianfabio Giorgioni, Antonio Di Stefano, et al.. (1992). Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands. Journal of Medicinal Chemistry. 35(23). 4408–4414. 18 indexed citations
11.
Ferrari, Francesca & Francesco Claudi. (1991). Behavioural evidence for central D-2 dopamine receptor agonistic effect by some 2-(fluorohydroxyphenyl)ethylamines. Pharmacology Biochemistry and Behavior. 38(1). 131–134. 12 indexed citations
12.
Claudi, Francesco, et al.. (1990). Synthesis and dopamine receptor affinities of 2-(4-fluoro-3-hydroxyphenyl)ethylamine and N-substituted derivatives. Journal of Medicinal Chemistry. 33(9). 2408–2412. 20 indexed citations
13.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, et al.. (1988). Heterocyclic quinones with potential antitumor activity. 2. Synthesis and antitumor activity of some benzimidazole-4,7-dione derivatives. Journal of Medicinal Chemistry. 31(1). 260–264. 34 indexed citations
15.
Antonini, Ippolito, et al.. (1985). One-Step Synthesis of 4-Alkoxy-1-Ethoxycarbonylmethylazetidin-2-ones. Synthetic Communications. 15(14). 1229–1232.
16.
Antonini, Ippolito, Francesco Claudi, G. Cristalli, et al.. (1983). ChemInform Abstract: SYNTHESIS OF 4‐AMINO‐1‐β‐D‐RIBOFURANOSYL‐1H‐PYRROLO(2,3‐B)PYRIDINE (1‐DEAZATUBERCIDIN) AS A POTENTIAL ANTITUMOR AGENT. Chemischer Informationsdienst. 14(11). 1 indexed citations
17.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, Mario Grifantini, & Sante Martelli. (1981). Thermal decomposition of 2‐amino‐3‐aziridino‐1,4‐naphthoquinones. Journal of Heterocyclic Chemistry. 18(2). 399–404. 1 indexed citations
18.
Antonini, Ippolito, Francesco Claudi, Gloria Cristalli, et al.. (1981). N*-N*-S* Tridentate ligand system as potential antitumor agents. Journal of Medicinal Chemistry. 24(10). 1181–1184. 31 indexed citations
19.
Casini, G., Francesco Claudi, Mario Grifantini, & Sante Martelli. (1974). Investigation on the isomerization of 2‐amino‐3‐aziridino‐1,4‐naphthoquinones to benzo[g]quinoxalines. Journal of Heterocyclic Chemistry. 11(3). 377–386. 6 indexed citations
20.
Claudi, Francesco, Palmarisa Franchetti, Mario Grifantini, & Sante Martelli. (1974). Isomerization of 4-(1-aziridinyl)quinazolines to 2,3-dihydroimidazo [1,2-c]quinazolines. The Journal of Organic Chemistry. 39(24). 3508–3511. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026